|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 1/00 | (2006.01) |
| A61P 11/00 | (2006.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61P 37/08 | (2006.01) |
| (11) | Number of the document | 3532499 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17794593.8 |
| Date of filing the European patent application | 2017-10-24 | |
| (97) | Date of publication of the European application | 2019-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation | 2021-08-10 |
| (86) | Number | PCT/US2017/058020 |
| Date | 2017-10-24 |
| (87) | Number | WO 2018/081075 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662414258 P | 2016-10-28 | US |
| (72) |
BENSCHOP, Robert Jan, US
DAVIES, Julian, US
OKRAGLY, Angela Jeannine, US
PATEL, Chetankumar Natvarlal, US
TRUHLAR, Stephanie Marie, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš IL-33 ir jų panaudojimas |
| ANTI-IL-33 ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-10-14 | 8 | 185.00 EUR |
| 2025-10-24 |